This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Ptc Therapeutics, Inc.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Innovations by Steven J Richards
Introduction
Steven J Richards is an accomplished inventor based in Brisbane, CA (US). He has made significant contributions to the field of oxidative stress disorders through his innovative research and development. With a total of 3 patents to his name, Richards continues to push the boundaries of scientific understanding and application.
Latest Patents
Richards' latest patents focus on fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for the treatment of oxidative stress disorders. These compounds and methods are designed to treat or suppress various conditions, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases, and diseases of aging. Additionally, his work aims to modulate, normalize, or enhance energy biomarkers, utilizing tocopherol quinone derivatives. Furthermore, he has disclosed compounds, compositions, and methods for the treatment of, or prophylaxis against, radiation exposure.
Career Highlights
Richards is currently associated with PTC Therapeutics, Inc., where he applies his expertise in developing innovative solutions for complex health issues. His work has garnered attention for its potential impact on improving patient outcomes in various medical fields.
Collaborations
Richards collaborates with notable professionals in his field, including Andrew W Hinman, to further enhance the scope and effectiveness of his research.
Conclusion
Steven J Richards exemplifies the spirit of innovation in the realm of medical research, particularly in addressing oxidative stress disorders. His contributions through patents and collaborations continue to pave the way for advancements in treatment methodologies.